IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar
(Reuters) - IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the anima...
2h ago
J&J advances $6.475 billion settlement of talc cancer lawsuits
By Dietrich Knauth NEW YORK(Reuters) - Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of t...
3h ago
CVS cuts 2024 profit forecast as insurance unit faces soaring medical costs
(Reuters) -CVS Health Corp slashed its annual profit forecast and missed Wall Street estimates for first-quarter earnings on ...
3h ago
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and better-than-expected demand for it...
3h ago
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
COPENHAGEN (Reuters) - Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing...
3h ago
Arizona Senate expected to vote on 1864 abortion ban repeal
By Brad Brooks (Reuters) - The Arizona Senate is expected to vote on Wednesday on a measure to repeal the state's 1864 ban on...
3h ago
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
(Reuters) - A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabete...
3h ago
UK's Smith+Nephew retains annual forecasts despite Q1 revenue miss
(Reuters) - British medical equipment maker Smith+Nephew retained its annual revenue and profit forecasts on Wednesday, despi...
6h ago
Haleon's first-quarter revenue misses expectations
(Reuters) - Consumer healthcare company Haleon's first-quarter revenue missed market estimates on Wednesday, due to retailer ...
7h ago
Novo Nordisk owner to invest $200 million in quantum computing startups
By Martin Coulter LONDON (Reuters) - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, sai...
7h ago